Swipe om te navigeren naar een ander artikel
This work was presented at the Society of Epidemiologic Research Conference in 2012—45th Annual Meeting, Minneapolis, MN, June 27–30 as a poster.
We investigated whether there is an association between increased risk for autism spectrum disorders (ASD) and selective serotonin reuptake inhibitors (SSRIs) used during pregnancy. This study used Denmark’s health and population registers to obtain information regarding prescription drugs, ASD diagnosis, and health and socioeconomic status. There were 1.5 % of cases and 0.7 % of controls exposed to SSRIs during the pregnancy period, and higher effect estimates observed with longer use. We found evidence that in utero exposure to SSRIs increases a child’s risk associated with ASD. These results, while adding to the limited knowledge on prenatal pharmacological exposures as potential ASD risk factors, need to be balanced against the benefits of indicated medication use by pregnant mothers.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Andrade, S. E., et al. (2008). Use of antidepressant medications during pregnancy: A multisite study. American Journal of Obstetrics and Gynecology, 198(194), e1–e5. PubMed
Bakker, M. K., Kerstjens-Frederikse, W. S., Buys, C. H., de Walle, H. E., & de Jong-van den Berg, L. T. (2010). First-trimester use of paroxetine and congenital heart defects: A population-based case–control study. Birth Defects Research Part A: Clinical and Molecular Teratology, 88, 94–100.
Bakker, M. K., Kolling, P., van den Berg, P. B., de Walle, H. E., & de Jong van den Berg, L. T. (2008). Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. British Journal of Clinical Pharmacology, 65, 600–606. PubMedCrossRefPubMedCentral
Bodnar, L. M., Siega-Riz, A. M., Simhan, H. N., Diesel, J. C., & Abrams, B. (2010). The impact of exposure misclassification on associations between prepregnancy BMI and adverse pregnancy outcomes. Obesity (Silver Spring), 18, 2184–2190. CrossRef
Burstyn, I., Sithole, F., & Zwaigenbaum, L. (2010). Autism spectrum disorders, maternal characteristics and obstetric complications among singletons born in Alberta, Canada. Chronic Diseases in Canada, 30, 125–134. PubMed
Carter, A. S., Garrity-Rokous, F. E., Chazan-Cohen, R., Little, C., & Briggs-Gowan, M. J. (2001). Maternal depression and comorbidity: Predicting early parenting, attachment security, and toddler social–emotional problems and competencies. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 18–26. PubMedCrossRef
Cooper, W. O., Willy, M. E., Pont, S. J., & Ray, W. A. (2007). Increasing use of antidepressants in pregnancy. American Journal of Obstetrics and Gynecology, 196(544), e1–e5.
Huot, R. L., Brennan, P. A., Stowe, Z. N., Plotsky, P. M., & Walker, E. F. (2004). Negative affect in offspring of depressed mothers is predicted by infant cortisol levels at 6 months and maternal depression during pregnancy, but not postpartum. Annals of the New York Academy of Sciences, 1032, 234–236. PubMedCrossRef
Jimenez-Solem, E., et al. (2012). Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: A nationwide cohort study. BMJ Open, 2, 1–9.
Kaae, J., Boyd, H. A., Hansen, A. V., Wulf, H. C., Wohlfahrt, J., & Melbye, M. (2010). Photosensitizing medication use and risk of skin cancer. Cancer Epidemiology Biomarkers & Prevention, 19, 2942–2949. CrossRef
Kanner, L. (1968). Autistic disturbances of affective contact. Acta Paedopsychiatr, 35, 100–136. PubMed
Lee, D., Majumdar, S. R., Lipton, H. L., Soumerai, S. B., Hennessy, S., & Davis, R. L. (2013). Special applications of pharmacoepidemiology. In B. L. Strom & S. E. Kimmel (Eds.), Textbook of pharmacoepidemiology (pp. 399–445). Philadelphia: Wiley. CrossRef
Yudell, M., Tabor, H. K., Dawson, G., Rossi, J., Newschaffer, C. (2013). Priorities for autism spectrum disorders risk communication and ethics. Autism, 17(6), 701–722.
- In Utero Exposure to Selective Serotonin Reuptake Inhibitors and Risk for Autism Spectrum Disorder
Nicole B. Gidaya
Brian K. Lee
Erik L. Mortensen
Craig J. Newschaffer
- Springer US